Carvedilol Tablet, Film Coated
Product Images NDC 68788-8231

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68788-8231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Tablets 25mg (8d3937b4 E0dd 4165 9825 Bbf5020d79f9 00)

Carvedilol Tablets, 25 mg, film-coated oral tablets labeled as generic for Coreg. The label shows storage instructions, manufacturer Advagen Pharma Limited, and directions for use in English and Spanish. It includes warnings to store below 30°C and keep out of reach of children. The labeler is Preferred Pharmaceuticals, Inc.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line graph depicting mortality percentage over time in months for two groups: one labeled "Placebo" and the other "Carvedilol." The graph shows lower mortality rates for the Carvedilol group compared to placebo, with p-value indicated as 0.0014.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot showing hazard ratios for different patient subgroups, including gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and use of spironolactone. The plot displays point estimates with confidence intervals, assessing the effect of treatment across these groups, with a vertical line at hazard ratio 1.0 as reference.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line graph showing cumulative percent mortality over a 24-month period comparing Carvedilol and placebo. The x-axis represents months, and the y-axis shows percent mortality up to 30%. The Carvedilol curve consistently lies below the placebo curve, with a noted P value of 0.03 indicating statistical significance.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A forest plot displaying hazard ratios with 95% confidence intervals for various subgroups of patients, including age, gender, timing post-myocardial infarction (MI), blood pressure, heart rate, diabetes status, and others. It compares variables such as prior beta-blocker use, Killip class, and presence of angina or hypertension in relation to hazard ratios.*

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure of carvedilol depicting its molecular arrangement including aromatic rings, hydroxyl groups, and an ether linkage, consistent with the active ingredient in carvedilol tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.